JAMES SPADONI: Open Payments
NPI 1316980261 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 56 payments from 8 companies in 2025. Trend: 2023 $743 · 2024 $1,632 · 2025 $1,309
Food & beverage: $1,309
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $437 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $236 |
| Janssen Pharmaceuticals, Inc | 6 | $192 |
| Neurocrine BioSciences, Inc. | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Lundbeck LLC | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
Products named: ARISTADA, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, COBENFY, REXULTI, HETLIOZ.
Industry payments across VA — which companies pay providers there.
